Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

50.85
-1.0200-1.97%
Post-market: 50.850.00000.00%16:43 EDT
Volume:1.60M
Turnover:81.58M
Market Cap:4.03B
PE:6.77
High:52.45
Open:52.24
Low:50.64
Close:51.87
Loading ...

Cautious Outlook on PTC Therapeutics Amid Regulatory and Financial Challenges

TIPRANKS
·
15 Jan

BRIEF-Orsini Chosen By PTC Therapeutics As Exclusive Specialty Pharmacy Provider For Adeno-Associated Virus Vector-Based Gene Therapy KEBILIDI™

Reuters
·
14 Jan

Orsini: Chosen by PTC Therapeutics as Exclusive Specialty Pharmacy Provider for Adeno-Associated Virus Vector-Based Gene Therapy Kebilidi

THOMSON REUTERS
·
14 Jan

PTC Therapeutics (PTCT) Gets a Sell from Bank of America Securities

TIPRANKS
·
14 Jan

PTC Therapeutics: Strong Financial Performance and Strategic Advancements Justify Buy Rating

TIPRANKS
·
14 Jan

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
14 Jan

PTC Therapeutics Surpasses Expectations with Strong 2024 Financials and Promising 2025 Outlook

TIPRANKS
·
14 Jan

PTC Therapeutics Surpasses Revenue Guidance for 2024

TIPRANKS
·
14 Jan

PTC Therapeutics sees FY25 revenue $600M-$800M, consensus $963.31M

TIPRANKS
·
13 Jan

PTC Therapeutics Inc: Anticipates Total Revenues for Full-Year 2025 to Be Between $600 Mln and $800 Mln

THOMSON REUTERS
·
13 Jan

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
13 Jan

RBC Cuts Price Target on PTC Therapeutics to $58 From $63, Keeps Outperform Rating

MT Newswires Live
·
07 Jan

Novartis' Gene Therapy Meets Primary Endpoint in SMA Study

Zacks
·
01 Jan

Novartis gene therapy helps children with rare muscle disorder in study

Reuters
·
30 Dec 2024